| 82.51 Delayed Data As of 6:30pm ET |  +0.48 / +0.59%Today’s Change | 66.10 Today|||52-Week Range 87.35 | +7.98% Year-to-Date |
| Previous close | 82.03 |
| Today’s open | 82.13 |
| Day’s range | 82.13 - 83.50 |
| Volume | 7,066,527 |
| Average volume (3 months) | 9,514,136 |
| Market cap | $211.6B |
| Earnings growth (last year) | +165.32% |
| Earnings growth (this year) | +12.90% |
| Earnings growth (next 5 years) | +9.50% |
| Revenue growth (last year) | +6.17% |
| P/E ratio | 23.1 |
| Price/Sales | 4.82 |
| Price/Book | 8.02 |
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | -0.33 | -0.90% |
| NVSNovartis | +0.39 | +0.45% |
| AZNAstraZeneca | +0.62 | +1.46% |
| SNYSanofi | +0.70 | +1.61% |
| Next reporting date | October 29, 2019 |
| EPS forecast (this quarter) | $1.23 |
| Annual revenue (last year) | $42.4B |
| Annual profit (last year) | $6.2B |
| Net profit margin | 14.65% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman, President & Chief Executive Officer Kenneth C. Frazier |
CFO & Executive Vice President-Global Services Robert M. Davis |
Corporate headquarters Kenilworth, New Jersey |
